BEGIN:VCALENDAR
PRODID:-//github.com/rianjs/ical.net//NONSGML ical.net 4.0//EN
VERSION:2.0
BEGIN:VEVENT
DESCRIPTION:As antibody-drug conjugates aspire to advance to earlier-line 
 treatments\, harnessing innovation has never been more important to redef
 ine the oncology standard of care and provide long-term benefit to patien
 ts.\n\nReturning as the annual touchpoint for the global community\, the 
 16th World ADC San Diego is THE week to fully immerse yourself in all thi
 ngs antibody-drug conjugate\, spotlighting the cutting-edge innovation em
 powering the industry to develop differentiated ADCs that show clear adva
 ntages against standard-of-care therapies with clinically meaningful pati
 ent benefit.\n\nWith 7 streams of end-to-end content spanning discovery c
 hemistry\, discovery biology\, preclinical\, translational medicine\, cli
 nical lessons\, process and analytical development\, and manufacturing an
 d supply chain: this is your one-stop bioconjugate shop to bring your tea
 m up to speed with ADC fundamentals\, get answers to the problems hinderi
 ng your ADC R and D\, and identify emerging trends to ensure you stay ahe
 ad of the curve.\n\nProviding unparalleled networking opportunities with 
 1\,400+ attendees from start-ups\, biotechs\, large pharma and leading se
 rvice providers\, anybody who is anybody in the ADC field will unite unde
 r one roof to innovate\, collaborate\, and redefine the standard of oncol
 ogy care.\n\nDate and Time: Monday\, 03 November 2025 at 08:00 to Thursda
 y\, 06 November 2025 at 16:00\n
DTEND:20251106T160000
DTSTAMP:20260514T152457Z
DTSTART:20251103T080000
LOCATION:Town and Country San Diego\, 500 Hotel Circle North\, San Diego\,
  California\, 92108\,
SEQUENCE:0
SUMMARY:As antibody-drug conjugates aspire to advance to earlier-line trea
 tments\, harnessing innovation has never been more important to redefine 
 the oncol...
UID:aaae62dc-ec19-4855-9b83-78d49c6b667b
END:VEVENT
END:VCALENDAR
